Skip to main content
SpringerLink
Log in

Pharmacodynamics, a tool for a better use of antibiotics?

  • Editorial
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. McKindley D, Fabian TC, Boucher BA, Croce MA, Proctor KG. (1995) Antibiotic pharmacokinetics following fluid resuscitation from traumatic shock. Arch Surg 130:1321–1329

    Article  PubMed  CAS  Google Scholar 

  2. Mimoz O, Jacolot A, Padoin C, Quillard J, Tod M, Louchahi K, Samii K, Petitjean O (1996) Influence of experimental rat model of multiple organ dysfunction on cefepime and amikacin pharmacokinetics. Antimicrob Agents Chemother 40:819–821

    PubMed Central  PubMed  CAS  Google Scholar 

  3. Van Dalen R, Vree TB (1990) Pharmacokinetics of antibiotics in critically ill patients. Intensive Care Med 16(suppl 3):S235–S238

    Article  PubMed  Google Scholar 

  4. Jacolot A, Incagnoli, Edouard AR, Tod M, Petitjean O, Samii K, Mimoz O (1999) Pharmacokinetics of cefpirome during the posttraumatic systemic inflammatory response syndrome. Intensive Care Med 25:486–491

    Article  PubMed  CAS  Google Scholar 

  5. Lipman J (2001) Low cefpirome levels during twice daily dosing in critically ill septic patients: pharmacokinetic modeling calls for more frequent dosing. Intensive Care Med 27: DOI:10.1007/s001340000741

  6. Craig WA (1993) The pharmacokinetics of cefpirome - rationale for a twelvehour dosing regimen. Scand J Infect Dis (suppl) 91:33–40

    CAS  Google Scholar 

  7. Paradis D, Vallee F, Allard S, Bisson C, Daviau N, Drapeau N, Auger F, LeBel M (1992) Comparative study of pharmacokinetics and serum bactericidal activities of cefpirome, ceftazidime, ceftriaxone, imipenem and ciprofloxacin. Antimicrob Agents Chemother 36:2085–2092

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  8. Moise P, Schentag J (1998) Pharmacokinetic and pharmacodynamic modelling of antibiotic therapy. Curr Opin Infect Dis 11:673–680

    Article  PubMed  CAS  Google Scholar 

  9. Craig WA (1998) Pharmacokinetic/ pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 26:1–12

    Article  PubMed  CAS  Google Scholar 

  10. Firsov AA, Vostrov SN, Shevchenko A, Portnoy YA, Zinner S (1998) A new approach to in vitro comparisons of antibiotics in dynamic models: equivalent area under the curve/MIC breakpoints and equi-efficient doses of trovafloxacin and ciprofloxacin against bacteria of similar susceptibilities. Antimicrob Agents Chemother 42:2841–2847

    PubMed Central  PubMed  CAS  Google Scholar 

  11. Corvaisier S, Maire PH, Bouvier d'Yvoire MY, Barbaut X, Bleyzac N, Jelliffe RW (1998) Comparisons between antimicrobial pharmacodynamic indices and bacterial killing as described by using the Zhi model. Antimicrob Agents Chemother 42:1731–1737

    PubMed Central  PubMed  CAS  Google Scholar 

  12. Thomas JK, Forrest A, Bhavnani M, Hyatt JM, Cheng A, Ballow CH, Schentag JJ (1998) Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy. Antimicrob Agents Chemother 42:521–527

    PubMed Central  PubMed  CAS  Google Scholar 

  13. Carmeli Y, Troillet N, Eliopoulos GM, Samore MH (1999) Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother 43:1379–1382

    PubMed Central  PubMed  CAS  Google Scholar 

  14. Manduru M, Mihm LB, White RL, Friedrich LV, Flume PA, Bosso JA (1997) Comparative bactericidal activity of ceftazidime against isolates of Pseudomonas aeruginosa as assessed in an in vitro pharmacodynamic model versus the traditional time-kill method. Antimicrob Agents Chemother 41:2527–2532

    PubMed Central  PubMed  CAS  Google Scholar 

  15. Yourassowsky E, Van der Linden MP, Lismont MJ, Crokaert F (1981) Early response of Pseudomonas aeruginosa growth curve to cefsulodin and n-formimidoyl thienamycin. In : Current chemotherapy and immunotherapy. Proceedings of the 12th International Congress of Chemotherapy, 1:514-516 (American Society for Microbiology, Washington, DC)

  16. Matzke GR, Frye RF, Joy MS, Palevsky PM (2000) Determinants of ceftazidime clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis. Antimicrob Agents Chemother 44:1639–1644

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  17. Turnidge JD (1998) The pharmacodynamics of P-lactams. Clin Infect Dis 27:10–22

    Article  PubMed  CAS  Google Scholar 

  18. Cappelletty DM (1999) Evaluation of several dosing regimens of cefepime, with various simulations of renal function, against clinical isolates of Pseudomonas aeruginosa in a pharmacodynamic infection model. Antimicrob Agents Chemother 43:129–133

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  19. Eng (1984) Examination of Gram-negative bacilli from meningitis patients who failed or relapsed on moxalactam therapy. Antimicrob Agents Chemother 26:850–856

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  20. Potel G, Chan NP, Pangon B, Fantin B, Vallois J-M, Faurisson F, Carbon C, (1991). Single daily dosing of antibiotics: importance of in vitro killing rate, serum half-life and protein binding. Antimicrob Agents Chemother 35:2085–2090

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  21. Vincent JL, (1997) Dear Sirs, I’m sorry to say that I don’t like you. Crit Care Med 25:372–374

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Laboratory, Infectious Disease Unit, Institut Jules Bordet, Free University of Brussels, 1 Rue Heger-Bordet, 1000, Brussels, Belgium

    F. Crokaert

Authors
  1. F. Crokaert
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F. Crokaert.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Crokaert, F. Pharmacodynamics, a tool for a better use of antibiotics?. Intensive Care Med 27, 340–343 (2001). https://doi.org/10.1007/s001340100865

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s001340100865

Search

Navigation